Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Axelrod

Showing results (71-80 of 233) with videos related to

Pageof 24
Sort By:
Prostaglandins and Medicine|February 1, 1981
Enhancement of ketosis by 16,16 dimethylprostaglandin E2 during the genesis of diabetic ketoacidosis in ratsL Axelrod, P Lloyd-Jones, A M Ferris, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1981
Malignant somatostatinoma: clinical features and metabolic studiesL Axelrod, M A Bush, H J Hirsch, et al.
The Journal of Clinical Investigation|August 1, 1972
Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusionR G Dluhy, L Axelrod, R H Underwood, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 29, 2018
Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetesCiarÁn E Fealy, Anny Mulya, Christopher L Axelrod, et al.
Diabetes|October 1, 1979
Persistence of ketosis despite suppression of lipolysis by 16,16-dimethylprostaglandin E2 in experimental diabetic ketoacidosis in ratsL Axelrod, S D Slowman, P Lloyd-Jones, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Ceftazidime concentrations in human aqueous humorJ L Axelrod, R S Kochman, M A Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2018
Biological Consequences of MHC-II Expression by Tumor Cells in CancerMargaret L Axelrod, Rebecca S Cook, Douglas B Johnson, et al.
American Journal of Ophthalmology|June 15, 1986
Human vitreous levels of cefamandole and moxalactamJ L Axelrod, R M Klein, R L Bergen, et al.
American Journal of Ophthalmology|October 15, 1985
Human vitreous levels of selected antistaphylococcal antibioticsJ L Axelrod, R M Klein, R L Bergen, et al.
Diabetes Care|January 1, 1994
Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled studyL Axelrod, J Camuso, E Williams, et al.
Pageof 24

Showing results (71-80 of 233) with videos related to

Sort By:
Pageof 24
Prostaglandins and Medicine|February 1, 1981
Enhancement of ketosis by 16,16 dimethylprostaglandin E2 during the genesis of diabetic ketoacidosis in ratsL Axelrod, P Lloyd-Jones, A M Ferris, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1981
Malignant somatostatinoma: clinical features and metabolic studiesL Axelrod, M A Bush, H J Hirsch, et al.
The Journal of Clinical Investigation|August 1, 1972
Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusionR G Dluhy, L Axelrod, R H Underwood, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 29, 2018
Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetesCiarÁn E Fealy, Anny Mulya, Christopher L Axelrod, et al.
Diabetes|October 1, 1979
Persistence of ketosis despite suppression of lipolysis by 16,16-dimethylprostaglandin E2 in experimental diabetic ketoacidosis in ratsL Axelrod, S D Slowman, P Lloyd-Jones, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1984
Ceftazidime concentrations in human aqueous humorJ L Axelrod, R S Kochman, M A Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2018
Biological Consequences of MHC-II Expression by Tumor Cells in CancerMargaret L Axelrod, Rebecca S Cook, Douglas B Johnson, et al.
American Journal of Ophthalmology|June 15, 1986
Human vitreous levels of cefamandole and moxalactamJ L Axelrod, R M Klein, R L Bergen, et al.
American Journal of Ophthalmology|October 15, 1985
Human vitreous levels of selected antistaphylococcal antibioticsJ L Axelrod, R M Klein, R L Bergen, et al.
Diabetes Care|January 1, 1994
Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled studyL Axelrod, J Camuso, E Williams, et al.
Pageof 24